Plain-English translation of NCT06365476 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called Extracorporeal Shock Wave Therapy (ESWT) to help reduce muscle stiffness in the forearms and hands of stroke survivors. The shock waves are directed at specific muscles in the forearm to improve flexibility and strength. Half of the participants will receive real shock wave treatment, while the other half will receive a placebo (fake treatment that looks the same) so researchers can measure how well the real treatment actually works.
After a stroke, many people develop stiffness and tightness in their arm and hand muscles that makes it hard to move and perform daily tasks. This trial exists to see whether shock wave therapy, a technique already used for other conditions, can safely and effectively reduce this stiffness and help stroke survivors regain better function.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic twice a week for two weeks (four sessions total). During each session, you will receive either real shock wave therapy or placebo treatment targeting the muscles in your forearm — you won't know which group you're in. The sessions take about 30–60 minutes, and researchers will assess your arm strength, movement, and function using various tests before treatment, and then again at 1 week, 4 weeks, 12 weeks, and 24 weeks after your final session to see how well the treatment worked.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Taiwan